Avoiding Pitfalls in the Statistical Analysis of Heterogeneous Tumors

por Axelrod, David E., Miller, Naomi, Chapman, Judith-Anne W.
Publicado 2009

Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment

por Tai, Patricia, Chapman, Judith-Anne W, Yu, Edward, Jones, Dennie, Yu, Changhong, Yuan, Fei, Sang-Joon, Lee
Publicado 2007

A pragmatic randomized waitlist-controlled effectiveness and cost-effectiveness trial of digital interventions for depression and anxiety

por Richards, Derek, Enrique, Angel, Eilert, Nora, Franklin, Matthew, Palacios, Jorge, Duffy, Daniel, Earley, Caroline, Chapman, Judith, Jell, Grace, Sollesse, Sarah, Timulak, Ladislav
Publicado 2020

Author Correction: A pragmatic randomized waitlist-controlled effectiveness and cost-effectiveness trial of digital interventions for depression and anxiety

por Richards, Derek, Enrique, Angel, Eilert, Nora, Franklin, Matthew, Palacios, Jorge, Duffy, Daniel, Earley, Caroline, Chapman, Judith, Jell, Grace, Sollesse, Sarah, Timulak, Ladislav
Publicado 2020

Effect of Quantitative Nuclear Image Features on Recurrence of Ductal Carcinoma In Situ (DCIS) of the Breast

por Axelrod, David E., Miller, Naomi A., Lickley, H. Lavina, Qian, Jin, Christens-Barry, William A., Yuan, Yan, Fu, Yuejiao, Chapman, Judith-Anne W.
Publicado 2008

Ductal carcinoma in situ of the breast (DCIS) with heterogeneity of nuclear grade: prognostic effects of quantitative nuclear assessment

por Chapman, Judith-Anne W, Miller, Naomi A, Lickley, H Lavina A, Qian, Jin, Christens-Barry, William A, Fu, Yuejiao, Yuan, Yan, Axelrod, David E
Publicado 2007

Heterogeneity Between Ducts of the Same Nuclear Grade Involved by Duct Carcinoma In Situ (DCIS) of the Breast

por Miller, Naomi A., Chapman, Judith-Anne W., Qian, Jin, Christens-Barry, William A., Fu, Yuejiao, Yuan, Yan, Lickley, H. Lavina A., Axelrod, David E.
Publicado 2010

Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC Cohort

por Chapman, Judith-Anne W, Nielsen, Torsten O, Ellis, Matthew J, Bernard, Phillip, Chia, Stephen, Gelmon, Karen A, Pritchard, Kathleen I, Maitre, Aurelie Le, Goss, Paul E, Leung, Samuel, Shepherd, Lois E, Bramwell, Vivien H C
Publicado 2013

A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22

por Trudeau, Maureen Elizabeth, Chapman, Judith-Anne W., Guo, Baoqing, Clemons, Mark J., Dent, Rebecca A., Jong, Roberta A., Kahn, Harriette J., Pritchard, Kathleen I., Han, Lei, O’Brien, Patti, Shepherd, Lois E., Parissenti, Amadeo M.
Publicado 2015

Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial

por Bramwell, Vivien HC, Tuck, Alan B, Chapman, Judith-Anne W, Anborgh, Pieter H, Postenka, Carl O, Al-Katib, Waleed, Shepherd, Lois E, Han, Lei, Wilson, Carolyn F, Pritchard, Kathleen I, Pollak, Michael N, Chambers, Ann F
Publicado 2014